25 XP   0   0   10

Sam Chun Dang Pharm. Co. Ltd
Buy, Hold or Sell?

Let's analyse Sam Chun Dang Pharm. Co. Ltd together

PenkeI guess you are interested in Sam Chun Dang Pharm. Co. Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sam Chun Dang Pharm. Co. Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sam Chun Dang Pharm. Co. Ltd

I send you an email if I find something interesting about Sam Chun Dang Pharm. Co. Ltd.

Quick analysis of Sam Chun Dang Pharm. Co. Ltd (30 sec.)










What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.03
When do you have the money?
1 year
How often do you get paid?
77.5%

What is your share worth?

Current worth
₩13,154.67
Expected worth in 1 year
₩18,436.37
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
₩5,321.08
Return On Investment
5.1%

For what price can you sell your share?

Current Price per Share
₩103,900.00
Expected price per share
₩72,100 - ₩151,200
How sure are you?
50%

1. Valuation of Sam Chun Dang Pharm. Co. Ltd (5 min.)




Live pricePrice per Share (EOD)

₩103,900.00

Intrinsic Value Per Share

₩-1,845.50 - ₩44,426.48

Total Value Per Share

₩11,309.17 - ₩57,581.14

2. Growth of Sam Chun Dang Pharm. Co. Ltd (5 min.)




Is Sam Chun Dang Pharm. Co. Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$208.9m$123.5m$46m27.1%

How much money is Sam Chun Dang Pharm. Co. Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m$1m-$2.8m-156.2%
Net Profit Margin-5.6%3.3%--

How much money comes from the company's main activities?

3. Financial Health of Sam Chun Dang Pharm. Co. Ltd (5 min.)




4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd? (5 min.)

Welcome investor! Sam Chun Dang Pharm. Co. Ltd's management wants to use your money to grow the business. In return you get a share of Sam Chun Dang Pharm. Co. Ltd.

What can you expect buying and holding a share of Sam Chun Dang Pharm. Co. Ltd?

First you should know what it really means to hold a share of Sam Chun Dang Pharm. Co. Ltd. And how you can make/lose money.

Speculation

The Price per Share of Sam Chun Dang Pharm. Co. Ltd is ₩103,900. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Sam Chun Dang Pharm. Co. Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Sam Chun Dang Pharm. Co. Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩13,154.67. Based on the TTM, the Book Value Change Per Share is ₩1,320.43 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-4.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩9.85 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Sam Chun Dang Pharm. Co. Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.150.0%-0.080.0%0.050.0%-0.020.0%0.040.0%
Usd Book Value Change Per Share0.370.0%0.920.0%0.000.0%0.120.0%0.130.0%
Usd Dividend Per Share0.000.0%0.010.0%0.040.0%0.030.0%0.040.0%
Usd Total Gains Per Share0.370.0%0.930.0%0.040.0%0.160.0%0.170.0%
Usd Price Per Share54.11-50.73-25.35-34.79-23.19-
Price to Earnings Ratio89.34-310.45-324.64-132.52-74.51-
Price-to-Total Gains Ratio145.12-131.53-305.53--25.19-40.28-
Price to Book Ratio5.88-6.96-4.54-5.67-3.83-
Price-to-Total Gains Ratio145.12-131.53-305.53--25.19-40.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share72.73
Number of shares13
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.03
Usd Book Value Change Per Share0.920.12
Usd Total Gains Per Share0.930.16
Gains per Quarter (13 shares)12.112.04
Gains per Year (13 shares)48.428.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10483826-2
2196863136
3114413451914
4119218272622
5224023093230
62288278103938
73336326124546
83385374145254
93433422165862
104481470176470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%6.06.00.050.0%12.08.00.060.0%30.09.01.075.0%34.09.01.077.3%
Book Value Change Per Share4.00.00.0100.0%7.05.00.058.3%12.08.00.060.0%30.010.00.075.0%33.011.00.075.0%
Dividend per Share1.00.03.025.0%8.00.04.066.7%15.00.05.075.0%31.00.09.077.5%34.00.010.077.3%
Total Gains per Share4.00.00.0100.0%7.05.00.058.3%13.07.00.065.0%32.08.00.080.0%36.08.00.081.8%

Fundamentals of Sam Chun Dang Pharm. Co. Ltd

About Sam Chun Dang Pharm. Co. Ltd

Sam Chun Dang Pharm. Co., Ltd manufactures, distributes, imports, and exports pharmaceuticals in South Korea. It provides ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company was founded in 1943 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-04-13 15:58:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Sam Chun Dang Pharm. Co. Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Sam Chun Dang Pharm. Co. Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 9.3% means that ₩0.09 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 9.3%. The company is making a profit. +1
  • The TTM is -5.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ9.3%TTM-5.6%+14.9%
TTM-5.6%YOY3.3%-8.9%
TTM-5.6%5Y-1.5%-4.1%
5Y-1.5%10Y3.3%-4.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3%10.3%-1.0%
TTM-5.6%9.4%-15.0%
YOY3.3%10.0%-6.7%
5Y-1.5%11.4%-12.9%
10Y3.3%11.0%-7.7%
1.1.2. Return on Assets

Shows how efficient Sam Chun Dang Pharm. Co. Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • 1.2% Return on Assets means that Sam Chun Dang Pharm. Co. Ltd generated ₩0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 1.2%. Using its assets, the company is less efficient in making profit.
  • The TTM is -0.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.2%TTM-0.6%+1.8%
TTM-0.6%YOY0.4%-1.0%
TTM-0.6%5Y-0.1%-0.5%
5Y-0.1%10Y0.7%-0.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2%5.7%-4.5%
TTM-0.6%5.7%-6.3%
YOY0.4%5.8%-5.4%
5Y-0.1%5.8%-5.9%
10Y0.7%6.7%-6.0%
1.1.3. Return on Equity

Shows how efficient Sam Chun Dang Pharm. Co. Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • 2.2% Return on Equity means Sam Chun Dang Pharm. Co. Ltd generated ₩0.02 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 2.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ2.2%TTM-1.3%+3.5%
TTM-1.3%YOY0.8%-2.1%
TTM-1.3%5Y-0.2%-1.1%
5Y-0.2%10Y1.1%-1.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2%8.8%-6.6%
TTM-1.3%8.8%-10.1%
YOY0.8%9.3%-8.5%
5Y-0.2%10.0%-10.2%
10Y1.1%11.2%-10.1%

1.2. Operating Efficiency of Sam Chun Dang Pharm. Co. Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Sam Chun Dang Pharm. Co. Ltd is operating .

  • Measures how much profit Sam Chun Dang Pharm. Co. Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY6.1%-6.1%
TTM-5Y2.0%-2.0%
5Y2.0%10Y3.1%-1.1%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.7%-11.7%
TTM-11.4%-11.4%
YOY6.1%13.8%-7.7%
5Y2.0%11.9%-9.9%
10Y3.1%13.2%-10.1%
1.2.2. Operating Ratio

Measures how efficient Sam Chun Dang Pharm. Co. Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.48 means that the operating costs are ₩1.48 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 1.485. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.215. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.485TTM1.215+0.270
TTM1.215YOY0.731+0.484
TTM1.2155Y0.833+0.382
5Y0.83310Y0.788+0.045
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4851.314+0.171
TTM1.2151.311-0.096
YOY0.7311.242-0.511
5Y0.8331.241-0.408
10Y0.7881.210-0.422

1.3. Liquidity of Sam Chun Dang Pharm. Co. Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Sam Chun Dang Pharm. Co. Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 2.83 means the company has ₩2.83 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 2.828. The company is able to pay all its short-term debts. +1
  • The TTM is 2.098. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.828TTM2.098+0.730
TTM2.098YOY4.144-2.046
TTM2.0985Y3.773-1.675
5Y3.77310Y2.743+1.031
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8281.959+0.869
TTM2.0981.959+0.139
YOY4.1442.156+1.988
5Y3.7732.109+1.664
10Y2.7432.053+0.690
1.3.2. Quick Ratio

Measures if Sam Chun Dang Pharm. Co. Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 1.43 means the company can pay off ₩1.43 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 1.428. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.744. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.428TTM1.744-0.317
TTM1.744YOY4.876-3.131
TTM1.7445Y3.635-1.890
5Y3.63510Y2.581+1.054
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4281.514-0.086
TTM1.7441.569+0.175
YOY4.8761.623+3.253
5Y3.6351.702+1.933
10Y2.5811.339+1.242

1.4. Solvency of Sam Chun Dang Pharm. Co. Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Sam Chun Dang Pharm. Co. Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.27 means that Sam Chun Dang Pharm. Co. Ltd assets are financed with 26.9% credit (debt) and the remaining percentage (100% - 26.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 0.269. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.401. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.269TTM0.401-0.132
TTM0.401YOY0.522-0.121
TTM0.4015Y0.433-0.032
5Y0.43310Y0.302+0.131
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2690.333-0.064
TTM0.4010.333+0.068
YOY0.5220.321+0.201
5Y0.4330.322+0.111
10Y0.3020.346-0.044
1.4.2. Debt to Equity Ratio

Measures if Sam Chun Dang Pharm. Co. Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 49.7% means that company has ₩0.50 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The MRQ is 0.497. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.807. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.497TTM0.807-0.310
TTM0.807YOY1.091-0.284
TTM0.8075Y0.836-0.029
5Y0.83610Y0.558+0.278
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4970.499-0.002
TTM0.8070.499+0.308
YOY1.0910.475+0.616
5Y0.8360.503+0.333
10Y0.5580.542+0.016

2. Market Valuation of Sam Chun Dang Pharm. Co. Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Sam Chun Dang Pharm. Co. Ltd generates.

  • Above 15 is considered overpriced but always compare Sam Chun Dang Pharm. Co. Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 89.34 means the investor is paying ₩89.34 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The EOD is 120.085. Based on the earnings, the company is expensive. -2
  • The MRQ is 89.342. Based on the earnings, the company is expensive. -2
  • The TTM is 310.454. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD120.085MRQ89.342+30.744
MRQ89.342TTM310.454-221.112
TTM310.454YOY324.639-14.185
TTM310.4545Y132.519+177.936
5Y132.51910Y74.514+58.005
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD120.08530.189+89.896
MRQ89.34224.133+65.209
TTM310.45424.133+286.321
YOY324.63925.004+299.635
5Y132.51926.701+105.818
10Y74.51427.094+47.420
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The EOD is 35.313. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 26.272. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -54.548. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD35.313MRQ26.272+9.041
MRQ26.272TTM-54.548+80.821
TTM-54.548YOY-38.762-15.787
TTM-54.5485Y-35.018-19.530
5Y-35.01810Y-7.797-27.222
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD35.31333.514+1.799
MRQ26.27220.307+5.965
TTM-54.54832.204-86.752
YOY-38.76230.927-69.689
5Y-35.01821.313-56.331
10Y-7.79725.291-33.088
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Sam Chun Dang Pharm. Co. Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 5.88 means the investor is paying ₩5.88 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Sam Chun Dang Pharm. Co. Ltd:

  • The EOD is 7.898. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.876. Based on the equity, the company is overpriced. -1
  • The TTM is 6.956. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.898MRQ5.876+2.022
MRQ5.876TTM6.956-1.080
TTM6.956YOY4.536+2.420
TTM6.9565Y5.674+1.282
5Y5.67410Y3.831+1.844
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD7.8983.783+4.115
MRQ5.8762.473+3.403
TTM6.9562.473+4.483
YOY4.5362.944+1.592
5Y5.6743.317+2.357
10Y3.8313.878-0.047
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sam Chun Dang Pharm. Co. Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--532.6521320.425-60%-4.007+101%177.108+201%189.615+181%
Book Value Per Share--13154.66810734.503+23%7995.396+65%8706.890+51%8258.996+59%
Current Ratio--2.8282.098+35%4.144-32%3.773-25%2.743+3%
Debt To Asset Ratio--0.2690.401-33%0.522-49%0.433-38%0.302-11%
Debt To Equity Ratio--0.4970.807-38%1.091-54%0.836-41%0.558-11%
Dividend Per Share---9.845-100%56.012-100%47.526-100%57.270-100%
Eps--216.304-114.956+153%66.131+227%-25.495+112%54.703+295%
Free Cash Flow Per Share--735.56714.254+5060%-205.911+128%-55.669+108%148.501+395%
Free Cash Flow To Equity Per Share--735.567444.611+65%111.526+560%179.014+311%285.400+158%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.975+3%
Intrinsic Value_10Y_max--44426.475--------
Intrinsic Value_10Y_min---1845.495--------
Intrinsic Value_1Y_max--1154.040--------
Intrinsic Value_1Y_min---532.865--------
Intrinsic Value_3Y_max--5980.733--------
Intrinsic Value_3Y_min---1309.175--------
Intrinsic Value_5Y_max--13837.528--------
Intrinsic Value_5Y_min---1759.661--------
Market Cap2224062620000.000+21%1753823291700.0001633428100225.000+7%799138898500.000+119%1090295431845.000+61%722393091372.500+143%
Net Profit Margin--0.093-0.056+160%0.033+181%-0.015+116%0.033+180%
Operating Margin----0%0.061-100%0.020-100%0.031-100%
Operating Ratio--1.4851.215+22%0.731+103%0.833+78%0.788+88%
Pb Ratio7.898+26%5.8766.956-16%4.536+30%5.674+4%3.831+53%
Pe Ratio120.085+26%89.342310.454-71%324.639-72%132.519-33%74.514+20%
Price Per Share103900.000+26%77300.00072475.000+7%36212.500+113%49695.000+56%33127.750+133%
Price To Free Cash Flow Ratio35.313+26%26.272-54.548+308%-38.762+248%-35.018+233%-7.797+130%
Price To Total Gains Ratio195.062+26%145.123131.532+10%305.533-53%-25.194+117%40.276+260%
Quick Ratio--1.4281.744-18%4.876-71%3.635-61%2.581-45%
Return On Assets--0.012-0.006+153%0.004+204%-0.001+109%0.007+76%
Return On Equity--0.022-0.013+158%0.008+171%-0.002+111%0.011+106%
Total Gains Per Share--532.6521330.270-60%52.004+924%224.634+137%246.885+116%
Usd Book Value--208922050.358169518798.145+23%123509909.441+69%133567629.264+56%125304819.011+67%
Usd Book Value Change Per Share--0.3730.924-60%-0.003+101%0.124+201%0.133+181%
Usd Book Value Per Share--9.2087.514+23%5.597+65%6.095+51%5.781+59%
Usd Dividend Per Share---0.007-100%0.039-100%0.033-100%0.040-100%
Usd Eps--0.151-0.080+153%0.046+227%-0.018+112%0.038+295%
Usd Free Cash Flow--11682257.923254562.284+4489%-3180835.474+127%-860519.091+107%2211959.723+428%
Usd Free Cash Flow Per Share--0.5150.010+5060%-0.144+128%-0.039+108%0.104+395%
Usd Free Cash Flow To Equity Per Share--0.5150.311+65%0.078+560%0.125+311%0.200+158%
Usd Market Cap1556843834.000+21%1227676304.1901143399670.158+7%559397228.950+119%763206802.292+61%505675163.961+143%
Usd Price Per Share72.730+26%54.11050.733+7%25.349+113%34.787+56%23.189+133%
Usd Profit--3435337.451-1816976.191+153%1021567.360+236%-406502.118+112%807429.576+325%
Usd Revenue--36743971.68433716990.232+9%31033696.754+18%31176027.423+18%28178063.831+30%
Usd Total Gains Per Share--0.3730.931-60%0.036+924%0.157+137%0.173+116%
 EOD+4 -4MRQTTM+24 -10YOY+25 -105Y+26 -910Y+27 -9

3.2. Fundamental Score

Let's check the fundamental score of Sam Chun Dang Pharm. Co. Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15120.085
Price to Book Ratio (EOD)Between0-17.898
Net Profit Margin (MRQ)Greater than00.093
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.428
Current Ratio (MRQ)Greater than12.828
Debt to Asset Ratio (MRQ)Less than10.269
Debt to Equity Ratio (MRQ)Less than10.497
Return on Equity (MRQ)Greater than0.150.022
Return on Assets (MRQ)Greater than0.050.012
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Sam Chun Dang Pharm. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.465
Ma 20Greater thanMa 50112,130.000
Ma 50Greater thanMa 10089,172.000
Ma 100Greater thanMa 20080,163.000
OpenGreater thanClose95,500.000
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  0-2-220-1-110



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in KRW. All numbers in thousands.

Summary
Total Assets408,021,822
Total Liabilities109,561,750
Total Stockholder Equity220,498,640
 As reported
Total Liabilities 109,561,750
Total Stockholder Equity+ 220,498,640
Total Assets = 408,021,822

Assets

Total Assets408,021,822
Total Current Assets163,905,938
Long-term Assets244,115,884
Total Current Assets
Cash And Cash Equivalents 40,427,236
Short-term Investments 52,316,741
Net Receivables 30,426,120
Inventory 35,262,549
Other Current Assets 60,842
Total Current Assets  (as reported)163,905,938
Total Current Assets  (calculated)158,493,488
+/- 5,412,450
Long-term Assets
Property Plant Equipment 90,008,846
Goodwill 3,745,081
Intangible Assets 92,555,523
Long-term Assets Other 0
Long-term Assets  (as reported)244,115,884
Long-term Assets  (calculated)186,309,450
+/- 57,806,434

Liabilities & Shareholders' Equity

Total Current Liabilities57,957,199
Long-term Liabilities51,604,551
Total Stockholder Equity220,498,640
Total Current Liabilities
Short Long Term Debt 32,225,990
Accounts payable 3,861,657
Other Current Liabilities 1,911,487
Total Current Liabilities  (as reported)57,957,199
Total Current Liabilities  (calculated)37,999,134
+/- 19,958,065
Long-term Liabilities
Long term Debt 16,000,000
Capital Lease Obligations Min Short Term Debt5,398,943
Long-term Liabilities Other 0
Long-term Liabilities  (as reported)51,604,551
Long-term Liabilities  (calculated)21,398,943
+/- 30,205,608
Total Stockholder Equity
Retained Earnings 106,015,414
Total Stockholder Equity (as reported)220,498,640
Total Stockholder Equity (calculated)106,015,414
+/- 114,483,226
Other
Capital Stock11,728,736
Common Stock Shares Outstanding 22,689
Net Debt 7,798,754
Net Invested Capital 268,724,630
Net Working Capital 105,948,739
Property Plant and Equipment Gross 156,605,205



Balance Sheet

Currency in KRW. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
118,204,920
123,443,031
127,827,531
155,378,650
159,831,378
162,511,808
168,442,151
172,490,847
171,174,146
173,017,326
180,350,978
184,260,203
187,802,246
193,611,970
199,295,326
205,113,463
210,940,399
215,540,228
222,891,131
235,143,417
241,361,802
244,596,118
242,169,841
261,158,440
265,390,933
271,276,486
283,175,879
290,150,966
291,086,043
290,127,871
308,298,061
317,078,866
345,331,804
345,546,175
343,639,552
345,996,602
361,470,284
365,302,011
375,762,736
372,793,050
393,813,672
403,547,425
407,822,828
408,021,822
408,021,822407,822,828403,547,425393,813,672372,793,050375,762,736365,302,011361,470,284345,996,602343,639,552345,546,175345,331,804317,078,866308,298,061290,127,871291,086,043290,150,966283,175,879271,276,486265,390,933261,158,440242,169,841244,596,118241,361,802235,143,417222,891,131215,540,228210,940,399205,113,463199,295,326193,611,970187,802,246184,260,203180,350,978173,017,326171,174,146172,490,847168,442,151162,511,808159,831,378155,378,650127,827,531123,443,031118,204,920
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
121,953,841
128,516,381
131,206,711
137,417,373
131,979,749
128,207,154
142,271,889
146,058,904
151,409,701
162,119,366
162,492,554
163,085,830
159,756,047
176,227,738
166,527,651
173,235,567
186,685,799
172,247,307
168,919,766
173,982,849
175,258,759
178,153,354
157,749,140
173,557,812
171,516,196
172,244,411
163,905,938
163,905,938172,244,411171,516,196173,557,812157,749,140178,153,354175,258,759173,982,849168,919,766172,247,307186,685,799173,235,567166,527,651176,227,738159,756,047163,085,830162,492,554162,119,366151,409,701146,058,904142,271,889128,207,154131,979,749137,417,373131,206,711128,516,381121,953,84100000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56,131,091
57,372,191
61,906,493
56,567,833
55,290,147
41,847,555
51,471,447
46,687,623
45,933,148
59,698,170
60,191,032
54,780,694
46,917,144
51,781,148
58,882,279
60,186,193
77,660,259
63,350,269
28,117
32,317
52,467
34,903
13,953
38,350
37,141
23,423,716
40,427,236
40,427,23623,423,71637,14138,35013,95334,90352,46732,31728,11763,350,26977,660,25960,186,19358,882,27951,781,14846,917,14454,780,69460,191,03259,698,17045,933,14846,687,62351,471,44741,847,55555,290,14756,567,83361,906,49357,372,19156,131,09100000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,206,227
1,206,227
1,177,095
7,947,335
7,947,335
19,000,000
29,292,930
31,300,000
38,300,000
38,300,000
39,084,293
0
0
0
38,030,725
47,060,497
36,928,640
36,914,100
47,911,629
64,881,830
59,604,497
63,587,975
64,147,606
72,189,768
67,163,970
68,261,920
52,316,741
52,316,74168,261,92067,163,97072,189,76864,147,60663,587,97559,604,49764,881,83047,911,62936,914,10036,928,64047,060,49738,030,72500039,084,29338,300,00038,300,00031,300,00029,292,93019,000,0007,947,3357,947,3351,177,0951,206,2271,206,22700000000000000000
       Net Receivables 
29,571,415
29,754,763
29,988,525
30,720,418
31,235,757
31,950,528
31,134,079
33,406,655
31,085,768
30,426,673
31,633,826
32,352,192
32,867,183
33,931,473
35,381,930
38,218,555
37,182,281
36,535,734
41,570,351
38,863,500
39,682,429
39,752,457
41,560,672
37,082,484
43,711,552
41,778,619
31,698,686
38,900,372
43,321,474
45,764,936
45,174,495
36,540,037
39,506,239
39,318,984
37,113,232
38,589,321
40,711,007
40,406,893
46,339,632
35,460,946
35,617,338
36,574,365
36,801,268
30,426,120
30,426,12036,801,26836,574,36535,617,33835,460,94646,339,63240,406,89340,711,00738,589,32137,113,23239,318,98439,506,23936,540,03745,174,49545,764,93643,321,47438,900,37231,698,68641,778,61943,711,55237,082,48441,560,67239,752,45739,682,42938,863,50041,570,35136,535,73437,182,28138,218,55535,381,93033,931,47332,867,18332,352,19231,633,82630,426,67331,085,76833,406,65531,134,07931,950,52831,235,75730,720,41829,988,52529,754,76329,571,415
       Other Current Assets 
579,930
726,293
1,160,000
584,510
1,900,354
760,273
889,898
903,469
736,646
833,240
756,160
738,745
1,296,236
1,325,637
991,024
970,883
629,299
310,039
687,070
1,183,845
3,922,945
1,038,495
1,057,721
661,267
831,041
1,032,678
521,058
798,708
783,694
3,626,192
2,982,583
2,589,036
2,482,349
4,846,374
4,539,926
260,253
160,790
253,510
2,273,506
56,188
56,636
56,379
59,181
60,842
60,84259,18156,37956,63656,1882,273,506253,510160,790260,2534,539,9264,846,3742,482,3492,589,0362,982,5833,626,192783,694798,708521,0581,032,678831,041661,2671,057,7211,038,4953,922,9451,183,845687,070310,039629,299970,883991,0241,325,6371,296,236738,745756,160833,240736,646903,469889,898760,2731,900,354584,5101,160,000726,293579,930
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215,526,786
220,255,860
232,031,229
235,578,417
244,115,884
244,115,884235,578,417232,031,229220,255,860215,526,786000000000000000000000000000000000000000
       Property Plant Equipment 
49,265,949
48,090,087
47,645,017
49,639,229
49,792,242
50,674,688
52,278,480
54,588,734
58,046,632
59,658,904
59,319,199
59,307,475
59,076,891
58,971,772
59,070,887
57,927,531
56,939,551
56,450,452
55,675,840
55,174,955
54,355,876
58,685,308
60,671,574
60,726,674
60,751,939
60,747,469
61,547,524
57,334,229
57,740,019
58,486,365
57,848,540
63,275,508
65,078,192
64,990,130
66,243,486
74,112,174
79,092,197
83,638,506
84,772,771
87,212,078
86,893,871
88,166,625
89,685,922
90,008,846
90,008,84689,685,92288,166,62586,893,87187,212,07884,772,77183,638,50679,092,19774,112,17466,243,48664,990,13065,078,19263,275,50857,848,54058,486,36557,740,01957,334,22961,547,52460,747,46960,751,93960,726,67460,671,57458,685,30854,355,87655,174,95555,675,84056,450,45256,939,55157,927,53159,070,88758,971,77259,076,89159,307,47559,319,19959,658,90458,046,63254,588,73452,278,48050,674,68849,792,24249,639,22947,645,01748,090,08749,265,949
       Goodwill 
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,081
3,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,0813,745,081
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,871,437
16,496,232
24,842,910
25,275,648
29,310,282
29,221,510
31,695,971
31,883,290
31,409,787
29,942,948
32,494,925
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000032,494,92529,942,94831,409,78731,883,29031,695,97129,221,51029,310,28225,275,64824,842,91016,496,23216,871,43700000000000000000
       Intangible Assets 
4,175,717
4,128,251
4,070,742
4,012,089
3,998,878
5,243,602
5,232,252
5,218,987
5,205,054
5,202,578
5,199,157
5,197,370
5,259,930
6,694,484
6,723,072
6,720,181
6,662,588
6,661,568
6,667,069
6,676,448
6,672,035
2,925,153
9,194,206
9,190,543
9,186,537
9,183,144
19,458,089
26,480,199
27,256,670
27,939,401
28,538,608
29,124,260
29,818,312
30,632,294
33,079,234
44,685,163
48,199,640
53,753,034
60,089,881
77,094,982
82,312,653
86,284,141
89,987,702
92,555,523
92,555,52389,987,70286,284,14182,312,65377,094,98260,089,88153,753,03448,199,64044,685,16333,079,23430,632,29429,818,31229,124,26028,538,60827,939,40127,256,67026,480,19919,458,0899,183,1449,186,5379,190,5439,194,2062,925,1536,672,0356,676,4486,667,0696,661,5686,662,5886,720,1816,723,0726,694,4845,259,9305,197,3705,199,1575,202,5785,205,0545,218,9875,232,2525,243,6023,998,8784,012,0894,070,7424,128,2514,175,717
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2
0
-1
0
0-10-20000000000000000000000000000000000000000
> Total Liabilities 
33,297,381
38,935,341
39,533,122
36,147,194
37,242,899
30,324,814
31,932,870
32,814,496
29,626,342
28,529,251
30,627,466
29,945,295
31,044,075
30,022,717
31,421,265
34,110,755
36,219,811
35,273,500
35,393,950
36,386,893
40,015,435
36,848,887
34,470,130
55,394,974
56,254,529
57,526,774
123,083,286
132,278,810
133,605,254
130,205,730
126,953,237
130,453,074
162,979,663
164,044,288
166,044,473
171,901,898
185,596,700
188,740,475
196,167,904
199,052,091
204,141,082
209,376,231
121,447,838
109,561,750
109,561,750121,447,838209,376,231204,141,082199,052,091196,167,904188,740,475185,596,700171,901,898166,044,473164,044,288162,979,663130,453,074126,953,237130,205,730133,605,254132,278,810123,083,28657,526,77456,254,52955,394,97434,470,13036,848,88740,015,43536,386,89335,393,95035,273,50036,219,81134,110,75531,421,26530,022,71731,044,07529,945,29530,627,46628,529,25129,626,34232,814,49631,932,87030,324,81437,242,89936,147,19439,533,12238,935,34133,297,381
   > Total Current Liabilities 
21,841,006
19,977,188
20,265,217
29,786,312
30,766,701
24,781,644
25,787,529
26,547,663
22,765,178
20,535,512
21,629,741
21,713,551
22,323,590
22,076,685
22,157,547
26,146,746
27,694,330
26,369,253
25,477,002
23,699,293
26,131,194
26,804,339
24,895,175
38,419,138
37,809,987
38,788,437
40,509,142
45,205,983
44,181,731
39,581,659
34,539,595
23,658,314
56,518,434
32,570,765
51,589,443
54,019,011
52,621,432
49,962,302
31,656,376
38,159,521
90,259,702
91,994,977
96,978,778
57,957,199
57,957,19996,978,77891,994,97790,259,70238,159,52131,656,37649,962,30252,621,43254,019,01151,589,44332,570,76556,518,43423,658,31434,539,59539,581,65944,181,73145,205,98340,509,14238,788,43737,809,98738,419,13824,895,17526,804,33926,131,19423,699,29325,477,00226,369,25327,694,33026,146,74622,157,54722,076,68522,323,59021,713,55121,629,74120,535,51222,765,17826,547,66325,787,52924,781,64430,766,70129,786,31220,265,21719,977,18821,841,006
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,195,635
7,365,073
5,336,425
5,244,812
3,000,000
3,000,000
0
10,867,279
0
2,877,077
2,439,279
2,591,934
2,818,187
12,622,162
2,011,004
1,820,327
1,989,944
2,273,210
1,579,730
1,980,246
3,051,205
2,928,845
2,755,729
22,814,876
22,932,345
0
0
0022,932,34522,814,8762,755,7292,928,8453,051,2051,980,2461,579,7302,273,2101,989,9441,820,3272,011,00412,622,1622,818,1872,591,9342,439,2792,877,077010,867,27903,000,0003,000,0005,244,8125,336,4257,365,0738,195,63500000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,195,635
7,365,073
5,336,425
5,244,812
3,000,000
3,000,000
0
10,867,279
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,755,729
58,835,629
59,221,506
65,730,975
32,225,990
32,225,99065,730,97559,221,50658,835,6292,755,7290000000000000010,867,27903,000,0003,000,0005,244,8125,336,4257,365,0738,195,63500000000000000000
       Accounts payable 
3,755,712
3,214,162
4,672,470
3,302,230
4,810,030
4,239,215
5,904,268
7,320,192
3,550,892
4,526,829
4,813,667
4,770,235
3,648,096
3,665,736
4,113,351
3,827,532
3,797,092
4,130,483
4,249,271
4,434,709
4,025,662
4,603,094
3,786,135
3,393,207
4,281,192
5,030,833
3,978,706
3,617,239
4,929,200
3,509,146
3,864,011
3,177,946
3,532,885
3,852,685
4,494,732
4,758,228
4,439,680
4,678,656
4,871,316
4,943,427
4,817,150
5,045,564
4,886,308
3,861,657
3,861,6574,886,3085,045,5644,817,1504,943,4274,871,3164,678,6564,439,6804,758,2284,494,7323,852,6853,532,8853,177,9463,864,0113,509,1464,929,2003,617,2393,978,7065,030,8334,281,1923,393,2073,786,1354,603,0944,025,6624,434,7094,249,2714,130,4833,797,0923,827,5324,113,3513,665,7363,648,0964,770,2354,813,6674,526,8293,550,8927,320,1925,904,2684,239,2154,810,0303,302,2304,672,4703,214,1623,755,712
       Other Current Liabilities 
8,874,324
8,771,326
9,302,292
10,659,677
9,759,264
10,571,667
10,209,850
14,093,176
13,602,905
11,353,637
11,222,646
12,312,422
13,575,540
13,043,898
13,449,550
15,340,063
16,612,630
14,043,135
13,862,658
16,928,159
19,860,720
11,570,806
10,918,300
12,490,389
13,938,045
13,563,034
13,468,027
17,014,272
17,452,055
12,092,956
9,536,064
11,106,032
17,489,056
16,595,140
15,708,780
18,638,986
17,697,693
12,718,929
13,334,972
1,771,229
1,773,488
1,795,947
0
1,911,487
1,911,48701,795,9471,773,4881,771,22913,334,97212,718,92917,697,69318,638,98615,708,78016,595,14017,489,05611,106,0329,536,06412,092,95617,452,05517,014,27213,468,02713,563,03413,938,04512,490,38910,918,30011,570,80619,860,72016,928,15913,862,65814,043,13516,612,63015,340,06313,449,55013,043,89813,575,54012,312,42211,222,64611,353,63713,602,90514,093,17610,209,85010,571,6679,759,26410,659,6779,302,2928,771,3268,874,324
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
89,474,742
41,923,351
43,658,882
24,469,060
51,604,551
51,604,55124,469,06043,658,88241,923,35189,474,742000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,682,416
9,573,265
9,514,446
9,921,061
12,215,555
24,148,837
23,222,792
48,566,266
28,891,769
29,247,874
49,529,792
51,827,652
72,224,053
72,504,864
24,499,521
24,551,587
0
0
0024,551,58724,499,52172,504,86472,224,05351,827,65249,529,79229,247,87428,891,76948,566,26623,222,79224,148,83712,215,5559,921,0619,514,4469,573,2657,682,41600000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,195,635
-7,365,073
-5,336,425
-5,244,812
-3,000,000
-3,000,000
0
-10,867,279
0
-2,877,077
-2,439,279
-2,591,934
-2,818,187
-12,622,162
-2,011,004
-1,820,327
-1,989,944
-2,273,210
-1,579,730
-1,980,246
-3,051,205
-2,928,845
3,256,616
-16,959,811
-16,972,566
5,642,022
5,398,943
5,398,9435,642,022-16,972,566-16,959,8113,256,616-2,928,845-3,051,205-1,980,246-1,579,730-2,273,210-1,989,944-1,820,327-2,011,004-12,622,162-2,818,187-2,591,934-2,439,279-2,877,0770-10,867,2790-3,000,000-3,000,000-5,244,812-5,336,425-7,365,073-8,195,63500000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,467,149
11,163,356
13,360,035
13,764,994
14,097,813
7,315,598
8,121,744
8,772,575
9,618,613
10,277,461
10,999,837
11,759,556
12,420,985
13,023,792
13,606,502
14,154,780
14,987,727
17,391,046
27,461,117
33,013,698
38,563,402
44,906,937
0
0
0
0
0
0000044,906,93738,563,40233,013,69827,461,11717,391,04614,987,72714,154,78013,606,50213,023,79212,420,98511,759,55610,999,83710,277,4619,618,6138,772,5758,121,7447,315,59814,097,81313,764,99413,360,03511,163,3569,467,14900000000000000000
> Total Stockholder Equity
80,858,029
81,762,086
85,187,985
93,122,654
95,348,035
101,274,263
104,037,232
105,440,495
106,330,774
107,720,156
111,138,023
114,316,524
116,264,988
121,274,723
123,713,906
125,166,062
127,707,814
131,095,597
135,652,480
146,339,390
148,094,050
152,588,433
150,657,700
148,518,372
150,458,940
152,811,175
160,092,593
157,872,156
157,480,789
159,922,141
181,344,824
186,625,792
182,352,140
181,501,887
177,595,080
174,094,704
175,873,584
176,561,536
179,594,832
173,740,959
189,672,590
194,171,194
210,585,565
220,498,640
220,498,640210,585,565194,171,194189,672,590173,740,959179,594,832176,561,536175,873,584174,094,704177,595,080181,501,887182,352,140186,625,792181,344,824159,922,141157,480,789157,872,156160,092,593152,811,175150,458,940148,518,372150,657,700152,588,433148,094,050146,339,390135,652,480131,095,597127,707,814125,166,062123,713,906121,274,723116,264,988114,316,524111,138,023107,720,156106,330,774105,440,495104,037,232101,274,26395,348,03593,122,65485,187,98581,762,08680,858,029
   Common Stock
10,000,000
10,000,000
10,000,000
10,000,000
10,000,000
10,526,454
10,526,454
10,526,454
10,526,454
10,526,454
10,618,583
10,618,583
10,618,583
10,671,228
10,671,228
11,000,262
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,052,907
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,384,021
11,533,397
11,533,397
0
0
0011,533,39711,533,39711,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,384,02111,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,052,90711,000,26210,671,22810,671,22810,618,58310,618,58310,618,58310,526,45410,526,45410,526,45410,526,45410,526,45410,000,00010,000,00010,000,00010,000,00010,000,000
   Retained Earnings 
57,932,837
60,382,948
63,668,032
0
0
0
0
0
0
0
77,494,569
0
0
0
0
0
0
102,773,008
107,365,635
111,080,921
119,458,353
123,991,206
121,965,781
120,001,443
121,889,387
124,181,190
131,490,191
128,792,637
128,392,119
130,864,826
121,824,692
126,987,000
122,740,162
121,405,030
117,321,760
112,514,106
114,292,042
115,022,540
117,682,425
112,078,576
112,404,168
113,009,663
101,209,072
106,015,414
106,015,414101,209,072113,009,663112,404,168112,078,576117,682,425115,022,540114,292,042112,514,106117,321,760121,405,030122,740,162126,987,000121,824,692130,864,826128,392,119128,792,637131,490,191124,181,190121,889,387120,001,443121,965,781123,991,206119,458,353111,080,921107,365,635102,773,00800000077,494,569000000063,668,03260,382,94857,932,837
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,595,514
16,595,514
16,609,132
16,525,339
46,911,312
46,911,312
46,911,312
46,911,312
46,911,312
46,911,312
46,997,034
46,997,034
47,194,174
47,282,563
62,502,818
66,648,927
0
0
0066,648,92762,502,81847,282,56347,194,17446,997,03446,997,03446,911,31246,911,31246,911,31246,911,31246,911,31246,911,31216,525,33916,609,13216,595,51416,595,51400000000000000000000000000
   Treasury Stock00000000-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327000-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327-1,988,327
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-135,181
-170,925
6,385,250
-237,522
-275,992
-181,300
-356,290
-303,666
-243,234
3,213,125
206,300
201,832
254,271
3,194,725
118,661
91,847
576,725
753,188
2,060,466
1,975,688
1,933,143
2,109,414
3,605,892
3,681,935
3,693,067
0
0
003,693,0673,681,9353,605,8922,109,4141,933,1431,975,6882,060,466753,188576,72591,847118,6613,194,725254,271201,832206,3003,213,125-243,234-303,666-356,290-181,300-275,992-237,5226,385,250-170,925-135,18100000000000000000



Balance Sheet

Currency in KRW. All numbers in thousands.




Cash Flow

Currency in KRW. All numbers in thousands.




Income Statement

Currency in KRW. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue192,668,516
Cost of Revenue-95,702,222
Gross Profit96,966,29396,966,293
 
Operating Income (+$)
Gross Profit96,966,293
Operating Expense-183,108,700
Operating Income9,559,815-86,142,407
 
Operating Expense (+$)
Research Development5,041,507
Selling General Administrative51,989,207
Selling And Marketing Expenses0
Operating Expense183,108,70057,030,714
 
Net Interest Income (+$)
Interest Income2,788,057
Interest Expense-2,577,066
Other Finance Cost-1
Net Interest Income210,992
 
Pretax Income (+$)
Operating Income9,559,815
Net Interest Income210,992
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,548,5209,559,815
EBIT - interestExpense = -2,577,066
-10,382,721
-7,805,655
Interest Expense2,577,066
Earnings Before Interest and Taxes (EBIT)0-1,971,454
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-4,548,520
Tax Provision--360,766
Net Income From Continuing Ops-4,187,754-4,187,754
Net Income-10,382,721
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-210,992
 

Technical Analysis of Sam Chun Dang Pharm. Co. Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Sam Chun Dang Pharm. Co. Ltd. The general trend of Sam Chun Dang Pharm. Co. Ltd is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Sam Chun Dang Pharm. Co. Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sam Chun Dang Pharm. Co. Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 151,200.

The bearish price targets are: 94,100 > 83,000 > 72,100.

Tweet this
Sam Chun Dang Pharm. Co. Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sam Chun Dang Pharm. Co. Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sam Chun Dang Pharm. Co. Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sam Chun Dang Pharm. Co. Ltd. The current macd is 2,342.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Sam Chun Dang Pharm. Co. Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Sam Chun Dang Pharm. Co. Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Sam Chun Dang Pharm. Co. Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Sam Chun Dang Pharm. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSam Chun Dang Pharm. Co. Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sam Chun Dang Pharm. Co. Ltd. The current adx is 23.33.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Sam Chun Dang Pharm. Co. Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Sam Chun Dang Pharm. Co. Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sam Chun Dang Pharm. Co. Ltd. The current sar is 118,290.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Sam Chun Dang Pharm. Co. Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sam Chun Dang Pharm. Co. Ltd. The current rsi is 51.47. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Sam Chun Dang Pharm. Co. Ltd Daily Relative Strength Index (RSI) ChartSam Chun Dang Pharm. Co. Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sam Chun Dang Pharm. Co. Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Sam Chun Dang Pharm. Co. Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sam Chun Dang Pharm. Co. Ltd Daily Stochastic Oscillator ChartSam Chun Dang Pharm. Co. Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sam Chun Dang Pharm. Co. Ltd. The current cci is -44.27945936.

Sam Chun Dang Pharm. Co. Ltd Daily Commodity Channel Index (CCI) ChartSam Chun Dang Pharm. Co. Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sam Chun Dang Pharm. Co. Ltd. The current cmo is -1.42823768.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Sam Chun Dang Pharm. Co. Ltd Daily Chande Momentum Oscillator (CMO) ChartSam Chun Dang Pharm. Co. Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sam Chun Dang Pharm. Co. Ltd. The current willr is -84.76702509.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Sam Chun Dang Pharm. Co. Ltd Daily Williams %R ChartSam Chun Dang Pharm. Co. Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sam Chun Dang Pharm. Co. Ltd.

Sam Chun Dang Pharm. Co. Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sam Chun Dang Pharm. Co. Ltd. The current atr is 9,606.

Sam Chun Dang Pharm. Co. Ltd Daily Average True Range (ATR) ChartSam Chun Dang Pharm. Co. Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sam Chun Dang Pharm. Co. Ltd. The current obv is 54,919,235.

Sam Chun Dang Pharm. Co. Ltd Daily On-Balance Volume (OBV) ChartSam Chun Dang Pharm. Co. Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sam Chun Dang Pharm. Co. Ltd. The current mfi is 20.03.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Sam Chun Dang Pharm. Co. Ltd Daily Money Flow Index (MFI) ChartSam Chun Dang Pharm. Co. Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sam Chun Dang Pharm. Co. Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

Sam Chun Dang Pharm. Co. Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sam Chun Dang Pharm. Co. Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.465
Ma 20Greater thanMa 50112,130.000
Ma 50Greater thanMa 10089,172.000
Ma 100Greater thanMa 20080,163.000
OpenGreater thanClose95,500.000
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Sam Chun Dang Pharm. Co. Ltd with someone you think should read this too:
  • Are you bullish or bearish on Sam Chun Dang Pharm. Co. Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Sam Chun Dang Pharm. Co. Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sam Chun Dang Pharm. Co. Ltd

I send you an email if I find something interesting about Sam Chun Dang Pharm. Co. Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sam Chun Dang Pharm. Co. Ltd.

Receive notifications about Sam Chun Dang Pharm. Co. Ltd in your mailbox!